• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血管生成因子血管抑制素在人脉络膜新生血管膜中的表达。

Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.

作者信息

Wakusawa Ryosuke, Abe Toshiaki, Sato Hajime, Yoshida Madoka, Kunikata Hiroshi, Sato Yasufumi, Nishida Kohji

机构信息

Department of Ophthalmology and Visual Science, Tohoku University Graduate School of Medicine, Miyagi, Japan.

出版信息

Am J Ophthalmol. 2008 Aug;146(2):235-243. doi: 10.1016/j.ajo.2008.03.019. Epub 2008 May 16.

DOI:10.1016/j.ajo.2008.03.019
PMID:18486097
Abstract

PURPOSE

To determine whether vasohibin, an antiangiogenic factor produced by vascular endothelial cells, is expressed in the choroidal neovascular (CNV) membranes obtained from human eyes with age-related macular degeneration (AMD) or polypoidal choroidal vasculopathy (PCV).

DESIGN

Retrospective, interventional case series.

METHODS

The medical charts of 21 eyes of 21 patients with AMD or PCV who underwent surgical removal of the CNV membrane were reviewed. The removed tissues were immunostained for von Willebrand Factor (vWF), vascular endothelial growth factor (VEGF), and vasohibin. The levels of the messenger ribonucleic acid of VEGF, VEGFR2, and vasohibin were determined by real-time reverse-transcriptase polymerase chain reaction (RT-PCR) from the CNV membranes excised from nine AMD and nine PCV patients.

RESULTS

The patients were divided into three groups; four patients were placed in the most active group (Group H), 13 in the less active group (Group E), and four in the nonactive group (Group S). Immunohistochemistry showed that vasohibin, vWF, and VEGF were expressed in the vascular endothelial cells in the CNV membranes and in the polypoidal vessels. RT-PCR showed that there was a strong correlation between the level of expression of VEGFR2 and vasohibin (P = .0002). Eyes with a lower vasohibin-to-VEGF ratio tended to have larger subretinal hemorrhages or vitreous hemorrhages, whereas eyes with higher vasohibin-to-VEGF ratio had subretinal fibrosislike lesions. Statistical analysis of the vasohibin-to-VEGF ratio among the three groups was significant (P = .0209).

CONCLUSIONS

Vasohibin is expressed in human CNV membranes. Our results indicate that the vasohibin-to-VEGF ratio may be related with the activity of the CNV.

摘要

目的

确定血管内皮细胞产生的抗血管生成因子血管抑制素是否在年龄相关性黄斑变性(AMD)或息肉状脉络膜血管病变(PCV)患者的人眼脉络膜新生血管(CNV)膜中表达。

设计

回顾性、介入性病例系列研究。

方法

回顾了21例接受CNV膜手术切除的AMD或PCV患者的21只眼的病历。对切除的组织进行免疫染色,检测血管性血友病因子(vWF)、血管内皮生长因子(VEGF)和血管抑制素。通过实时逆转录聚合酶链反应(RT-PCR)测定从9例AMD和9例PCV患者切除的CNV膜中VEGF、VEGFR2和血管抑制素的信使核糖核酸水平。

结果

患者分为三组;4例患者归入最活跃组(H组),13例归入较不活跃组(E组),4例归入非活跃组(S组)。免疫组织化学显示,血管抑制素、vWF和VEGF在CNV膜的血管内皮细胞和息肉状血管中表达。RT-PCR显示,VEGFR2和血管抑制素的表达水平之间存在强相关性(P = 0 . 0002)。血管抑制素与VEGF比值较低的眼往往有较大的视网膜下出血或玻璃体积血,而血管抑制素与VEGF比值较高的眼有视网膜下纤维化样病变。三组间血管抑制素与VEGF比值的统计学分析具有显著性(P = 0 . 0209)。

结论

血管抑制素在人CNV膜中表达。我们的结果表明,血管抑制素与VEGF的比值可能与CNV的活性有关。

相似文献

1
Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.抗血管生成因子血管抑制素在人脉络膜新生血管膜中的表达。
Am J Ophthalmol. 2008 Aug;146(2):235-243. doi: 10.1016/j.ajo.2008.03.019. Epub 2008 May 16.
2
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.息肉样脉络膜血管病变和脉络膜新生血管中血管内皮生长因子和色素上皮衍生因子的房水水平。
Am J Ophthalmol. 2006 Mar;141(3):456-62. doi: 10.1016/j.ajo.2005.10.012.
3
Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration.血管内皮生长因子和血管生成素在年龄相关性黄斑变性患者黄斑中心凹下膜中的表达。
Am J Ophthalmol. 2005 Apr;139(4):589-96. doi: 10.1016/j.ajo.2004.11.064.
4
Neuropilin-1 expression by endothelial cells and retinal pigment epithelial cells in choroidal neovascular membranes.脉络膜新生血管膜中内皮细胞和视网膜色素上皮细胞的神经纤毛蛋白-1表达。
Am J Ophthalmol. 2005 Dec;140(6):1044-1050. doi: 10.1016/j.ajo.2005.07.021.
5
Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.年龄相关性黄斑变性中氧化脂蛋白的清道夫受体
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1801-7. doi: 10.1167/iovs.06-0699.
6
Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.抗血管内皮生长因子 A/血管内皮生长因子受体 2 或非特异性 siRNA 抑制小鼠实验性脉络膜新生血管形成。
Exp Eye Res. 2010 Sep;91(3):433-9. doi: 10.1016/j.exer.2010.06.019. Epub 2010 Jul 1.
7
Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.息肉样脉络膜血管病变患者和新生血管性年龄相关性黄斑变性患者的C反应蛋白水平升高。
Ophthalmology. 2007 Sep;114(9):1722-7. doi: 10.1016/j.ophtha.2006.12.021. Epub 2007 Apr 2.
8
Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.血管内皮生长因子的差异表达提示翼状胬肉起源于角膜缘。
Ophthalmology. 2005 Jun;112(6):1023-30. doi: 10.1016/j.ophtha.2005.01.023.
9
Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.血管内皮衍生的血管生成抑制剂血管抑肽-1抑制脉络膜新生血管。
Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3272-80. doi: 10.1167/iovs.10-6295.
10
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.鬼臼苦素(PPP)对胰岛素样生长因子-1受体的抑制作用及其对VEGF分泌和实验性脉络膜新生血管形成的影响
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2620-6. doi: 10.1167/iovs.07-0742.

引用本文的文献

1
Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.新生血管性年龄相关性黄斑变性和息肉状脉络膜血管病变患者对康柏西普治疗反应的代谢组学研究
Front Pharmacol. 2022 Sep 19;13:991879. doi: 10.3389/fphar.2022.991879. eCollection 2022.
2
A review on vasohibin and ocular neovascularization.血管抑制素与眼部新生血管形成的综述。
Int J Ophthalmol. 2020 Jun 18;13(6):1004-1008. doi: 10.18240/ijo.2020.06.22. eCollection 2020.
3
Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression.
慢性肾脏病中的内源性血管生成抑制因子:进展的潜在生物标志物。
Int J Mol Sci. 2018 Jun 24;19(7):1859. doi: 10.3390/ijms19071859.
4
The expression of vasohibin-1 and its prognostic significance in bladder cancer.血管抑制素-1在膀胱癌中的表达及其预后意义
Exp Ther Med. 2017 Oct;14(4):3477-3484. doi: 10.3892/etm.2017.4969. Epub 2017 Aug 18.
5
The roles of vasohibin and its family members: Beyond angiogenesis modulators.血管抑素及其家族成员的作用:超越血管生成调节剂。
Cancer Biol Ther. 2017 Nov 2;18(11):827-832. doi: 10.1080/15384047.2017.1373217. Epub 2017 Sep 8.
6
The Vasohibin Family.血管抑制素家族
Pharmaceuticals (Basel). 2010 Feb 5;3(2):433-440. doi: 10.3390/ph3020433.
7
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.血管生成调节因子血管抑制素-1可抑制卵巢癌生长和腹膜播散,并延长宿主生存期。
Int J Oncol. 2015 Dec;47(6):2057-63. doi: 10.3892/ijo.2015.3193. Epub 2015 Oct 8.
8
Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.血管抑制素家族在胎儿胎盘血管生成和合体滋养层细胞形成调控中的作用。
PLoS One. 2014 Sep 3;9(9):e104728. doi: 10.1371/journal.pone.0104728. eCollection 2014.
9
The vasohibin family: a novel family for angiogenesis regulation.血管生成素家族:调控血管生成的新家族。
J Biochem. 2013 Jan;153(1):5-11. doi: 10.1093/jb/mvs128. Epub 2012 Oct 25.
10
Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix.源自细胞外基质的蛋白水解衍生内源性血管生成抑制剂。
Pharmaceuticals (Basel). 2011 Dec;4(12):1551-1577. doi: 10.3390/ph4121551.